ZVIA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zevia PBC (ZVIA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with declining revenue, net income, and EPS. Technical indicators show a bearish trend, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. Analysts have lowered price targets, and there is no recent news or influential trading activity to support a bullish case. Given the investor's profile and the lack of compelling reasons to invest, holding off on this stock is recommended.
The technical indicators suggest a bearish trend. The MACD is slightly positive but expanding, while the RSI is neutral at 32.08. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels. Support is at 1.191, and resistance is at 1.604.
NULL identified. No recent news or significant insider/hedge fund activity. Analysts note some progress on the company's turnaround efforts, but this is overshadowed by weak financials.
Declining financial performance in Q4 2025, including revenue (-4.03% YoY), net income (-77.25% YoY), and EPS (-80.00% YoY). Analysts have lowered price targets, and there is no recent congress trading data or influential trading activity.
In Q4 2025, Zevia reported a revenue drop to $37.87M (-4.03% YoY), net income of -$1.31M (-77.25% YoY), and EPS of -0.02 (-80.00% YoY). Gross margin also declined to 47.27% (-2.50% YoY).
Analysts have lowered price targets: Morgan Stanley to $1.75 (from $2.90), Telsey Advisory to $5 (from $6), and Goldman Sachs to $3 (from $3.50). Ratings are mixed, with Neutral and Equal Weight ratings dominating.
